179 related articles for article (PubMed ID: 24510513)
1. Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy.
Wei Y; Zhou T; Zhu J; Zhang Y; Sun M; Ding X; Wang D; Li H; Li B
Cell Biochem Biophys; 2014 Jul; 69(3):433-7. PubMed ID: 24510513
[TBL] [Abstract][Full Text] [Related]
2. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
Chan SH; Ng WT; Kam KL; Lee MC; Choi CW; Yau TK; Lee AW; Chow SK
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1335-42. PubMed ID: 18922648
[TBL] [Abstract][Full Text] [Related]
3. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study.
Low WK; Toh ST; Wee J; Fook-Chong SM; Wang DY
J Clin Oncol; 2006 Apr; 24(12):1904-9. PubMed ID: 16622266
[TBL] [Abstract][Full Text] [Related]
4. Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients.
Petsuksiri J; Sermsree A; Thephamongkhol K; Keskool P; Thongyai K; Chansilpa Y; Pattaranutaporn P
Radiat Oncol; 2011 Feb; 6():19. PubMed ID: 21333025
[TBL] [Abstract][Full Text] [Related]
5. Sensorineural Hearing Loss in Nasopharyngeal Carcinoma Survivors in the Modern Treatment Era - The Early and Late Effects of Radiation and Cisplatin.
Yip PL; Mok KCJ; Ho HS; Lee WYV; Wong ACL; Lau CT; Wong FCS; Yeung KW; Lee SF
Clin Oncol (R Coll Radiol); 2022 Apr; 34(4):e160-e167. PubMed ID: 34772581
[TBL] [Abstract][Full Text] [Related]
6. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
7. Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.
Scobioala S; Parfitt R; Matulat P; Kittel C; Ebrahimi F; Wolters H; Am Zehnhoff-Dinnesen A; Eich HT
Strahlenther Onkol; 2017 Nov; 193(11):910-920. PubMed ID: 28887665
[TBL] [Abstract][Full Text] [Related]
8. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.
Chen WC; Jackson A; Budnick AS; Pfister DG; Kraus DH; Hunt MA; Stambuk H; Levegrun S; Wolden SL
Cancer; 2006 Feb; 106(4):820-9. PubMed ID: 16421885
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Zhu W; Chen F; Li J; Wang W; Zhang H; Yang G; Zou L; Zhu Y; Yuan W; Ding H; Song X; Wang S
Acta Otolaryngol; 2019 Mar; 139(3):263-268. PubMed ID: 30870056
[TBL] [Abstract][Full Text] [Related]
10. Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma.
Oh YT; Kim CH; Choi JH; Kang SH; Chun M
Radiother Oncol; 2004 Jul; 72(1):79-82. PubMed ID: 15236878
[TBL] [Abstract][Full Text] [Related]
11. Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature.
Theunissen EA; Bosma SC; Zuur CL; Spijker R; van der Baan S; Dreschler WA; de Boer JP; Balm AJ; Rasch CR
Head Neck; 2015 Feb; 37(2):281-92. PubMed ID: 24478269
[TBL] [Abstract][Full Text] [Related]
12. Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients.
Mahdavi SR; Rezaeyan A; Nikoofar A; Bakhshandeh M; Farahani S; Cheraghi S
J Cancer Res Ther; 2020; 16(3):539-545. PubMed ID: 32719264
[TBL] [Abstract][Full Text] [Related]
13. Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China.
Chen Y; Sun Y; Liang SB; Zong JF; Li WF; Chen M; Chen L; Mao YP; Tang LL; Guo Y; Lin AH; Liu MZ; Ma J
Cancer; 2013 Jun; 119(12):2230-8. PubMed ID: 23576020
[TBL] [Abstract][Full Text] [Related]
14. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Das N; Kaushal D; Patro SK; Pareek P; Dixit A; Soni K; Prakasan Nair N; Choudhury B; Goyal A
Acta Otolaryngol; 2021 Sep; 141(9):885-893. PubMed ID: 34486907
[TBL] [Abstract][Full Text] [Related]
15. Hearing Assessment after Treatment of Nasopharyngeal Carcinoma with CRT and IMRT Techniques.
Hwang CF; Fang FM; Zhuo MY; Yang CH; Yang LN; Hsieh HS
Biomed Res Int; 2015; 2015():769806. PubMed ID: 26351638
[TBL] [Abstract][Full Text] [Related]
16. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment.
Kwong DL; Wei WI; Sham JS; Ho WK; Yuen PW; Chua DT; Au DK; Wu PM; Choy DT
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):281-9. PubMed ID: 8892450
[TBL] [Abstract][Full Text] [Related]
17. Incidence of long-term ipsilateral and contralateral ototoxicity following radiotherapy for nasopharyngeal carcinoma.
Wakisaka H; Yamada H; Motoyoshi K; Ugumori T; Takahashi H; Hyodo M
Auris Nasus Larynx; 2011 Feb; 38(1):95-100. PubMed ID: 20541337
[TBL] [Abstract][Full Text] [Related]
18. Effect of radiotherapy on retro-cochlear auditory pathways.
Low WK; Burgess R; Fong KW; Wang DY
Laryngoscope; 2005 Oct; 115(10):1823-6. PubMed ID: 16222203
[TBL] [Abstract][Full Text] [Related]
19. [Ototoxicity in head and neck cancers after radiotherapy and chemoradiotherapy: From primary prevention to tertiary prevention].
Espenel S; Garcia MA; Guy JB; Vallard A; Ben Mrad M; Langrand-Escure J; El Meddeb Hamrouni A; Trone JC; Xia Y; Rancoule C; Magné N
Cancer Radiother; 2017 Feb; 21(1):77-83. PubMed ID: 28189351
[TBL] [Abstract][Full Text] [Related]
20. Sensorineural hearing loss following induction chemotherapy plus concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma.
Atchariyasathian V; Pruegsanusak K; Wongsriwattanakul S
J Laryngol Otol; 2015 Aug; 129(8):767-72. PubMed ID: 26112091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
